Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

63.35 +0.80 (+1.28%)
Official Closing Price Updated: 7:00 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Palantir, Hims & Hers, American Eagle, Joby Aviation And AMD: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. indices ended Monday in the green with the Dow Jones Industrial Average rising 1.3% higher at 44,173.64. 
Via Benzinga
Topics Stocks
Hims & Hers Tumbles After-Hours On Q2 Miss, GLP-1 Slowdown — But Retail Traders Eye Bargain Entry
Via Stocktwits
Hims & Hers (HIMS) Q2 Revenue Jumps 73%
Via The Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Which stocks are moving after the closing bell on Monday?
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Earnings Scheduled For August 4, 2025
 
Via Benzinga
What Does the Market Think About Hims & Hers Health?
 
Via Benzinga
Hims & Hers Health (NYSE:HIMS) Misses Q2 Revenue Estimates, Stock Drops 12%
Telehealth company Hims & Hers Health (NYSE:HIMS) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 72.6% year on year to $544.8 million. On the other hand, the company... 
Via StockStory
Hims & Hers Health Stock Tumbles On Q2 Earnings As Revenue Comes Up Short, Company Sees 'Exciting Period Of Growth' Ahead
Hims & Hers Health reports second-quarter revenue of $544.83 million, missing analyst estimates of $549.83 million. 
Via Benzinga
IBD 50's Hims & Hers Plummets 9% On Second-Quarter Sales Miss
The company reiterated its sales outlook for the year, despite coming in with lighter-than-expected second-quarter sales. 
Via Investor's Business Daily
Topics ETFs Earnings
Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results
From Hims & Hers
Via Business Wire
Hims & Hers Health Earnings Preview
 
Via Benzinga
Check Out What Whales Are Doing With HIMS
 
Via Benzinga
Class Action Reminder for HIMS Investors: Kessler Topaz Meltzer &amp; Check, LLP Reminds Hims &amp; Hers Health, Inc. (HIMS) Investors of Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
Class Action Reminder for HIMS Investors: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Securities Fraud Class Action Lawsuit
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Hims & Hers Health, Inc. (HIMS) Shareholders
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Hims &amp; Hers Health, Inc. (HIMS) Shareholders
Via TheNewswire.com
Topics Fraud Lawsuit
HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
This Biotech Stock Could Soar on Upcoming Clinical Data
This weight loss drugmaker may be significantly undervalued right now. 
Via The Motley Fool
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
These top telehealth stocks look like smart growth plays right now. 
Via The Motley Fool
HIMS CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors - A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (HIMS)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
HIMS CLASS ACTION FILED: Kessler Topaz Meltzer &amp; Check, LLP Reminds Investors - A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims &amp; Hers Health, Inc. (HIMS)
Via TheNewswire.com
Topics Fraud Lawsuit
What To Expect From Hims & Hers Health’s (HIMS) Q2 Earnings
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
HIMS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS
From The Rosen Law Firm PA
Via GlobeNewswire
Will Hims & Hers Fall Along With Novo Nordisk?
Novo Nordisk shares are trading as low as 35% of their 52-week highs, making Hims & Hers investors nervous whether a selloff is coming. 
Via MarketBeat
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims & Hers Health, Inc. Lawsuit - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims &amp; Hers Health, Inc. Lawsuit - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
From Pomerantz LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.